Commentary by Ilana Bragin MD, PGY-3
This week online in the NEJM, the results of a trial known as Jupiter were presented in an article that will likely change the way we approach cardiovascular health protection. The Jupiter …
Category: Journal Club
Clinical Correlations
Perioperative Beta-blockade: Will POISE Change Management?
September 10, 2008
Commentary by Michael LoCurcio MD, Michael Janjigian MD and Michael C Brabeck MD, FACP, NYU Division of General Internal Medicine
Cardiovascular complications continue to be a major cause of morbidity and mortality in the perioperative …
Not So Rosi…
May 24, 2007
Commentary by Seagram Villagomez MD, Chief Resident
Since its approval in 1999, nearly 1 million Americans have used the thiazolidinedione (TZD) rosiglitazone (Avandia – GlaxoSmithKline) for the treatment of Type 2 Diabetes. However, in a drug class which seems …
How Do You Estimate Stroke Risk After a Transient Ischemic Attack?
April 24, 2007
By: Alana Choy-Shan, MD PGY-3
Transient ischemic attacks (TIAs) are known to be a harbinger of stroke, however it is difficult for physicians to estimate individual stroke risk. Previously, the two systems used to predict short-term risk of stroke after a TIA …
New Guidelines on the Diagnosis and Treatment of Venous Thromboembolism-Part 2
April 19, 2007
Commentary By: Margaret Horlick, MD, PGY-3
New guidelines on the diagnosis and treatment of venous thromboembolism (VTE) were recently jointly issued by the American Academy of Family Physicians and the American College of Physicians. The guidelines are based on a systematic review …
New Guidelines on the Diagnosis and Treatment of Venous Thromboembolism-Part 1
April 12, 2007
Commentary By: Margaret Horlick, MD, PGY-3
New guidelines on the diagnosis and treatment of venous thromboembolism (VTE) were recently jointly issued by the American Academy of Family Physicians and the American College of Physicians. The guidelines are based on a systematic review …
Does Screening for Lung Cancer Improve Mortality?
April 10, 2007
Commentary By: Anna Dvorak, MDPGY-3
Lung cancer is the number one cause of cancer mortality in both men and women. Screening patients at risk for lung cancer might reduce mortality if it helps find cancers at an early stage while they are still …
The COURAGE Trial: PCI is not superior to medical therapy in patients with stable coronary disease
March 27, 2007
Commentary by Cara Litvin, PGY-3
The results of one of the more remarkable studies from the meeting of the American College of Cardiology were presented on Monday, along with the simultaneous early publishing of the study online in the New England Journal of Medicine. …